Neurological Disorders Associated with Glutamic Acid Decarboxylase Antibodies

  • Herard K
  • Khanni J
  • Alusma- Hibbert K
  • et al.
N/ACitations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Anti-glutamic acid decarboxylase (GAD) antibodies have been discovered in a variety of neurological syndromes with unique presentations. These syndromes include limbic encephalitis (LE), stiff person syndrome (SPS), opsoclonus-myoclonus-ataxia syndrome, cerebellar ataxia, status epilepticus, and palatal myoclonus among others. We present two patients who presented with Guillain-Barré (GBS) and myasthenia gravis (MG) like syndromes, who were found to have anti-GAD antibodies. These case reports highlight the complex presentation of patients with neurological disorders associated with anti-GAD antibodies. The proper identification of anti-GAD antibody's presence has proven to be beneficial in treatment and provide enhanced quality of life.

Cite

CITATION STYLE

APA

Herard, K., Khanni, J. L., Alusma- Hibbert, K., Samuels, C. R., & Espinosa, P. S. (2019). Neurological Disorders Associated with Glutamic Acid Decarboxylase Antibodies. Cureus. https://doi.org/10.7759/cureus.4738

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free